Angela Lombardi,Anna Grimaldi,Silvia Zappavigna et al.
Angela Lombardi et al.
HCC is the third leading cause of cancer-related deaths worldwide, accounting for about 1 million deaths annually. The incidence of HCC is highest in Asia and Africa, where the endemic high prevalence of hepatitis B and hepatitis C strongly...
Carmela Loguercio
Carmela Loguercio
Moxifloxacin, but not Metronidazole can be used in therapeutic regimens against Helicobacter pylori [0.03%]
莫西沙星可被用于治疗幽门螺旋杆菌的疗程中，甲硝唑则不可以
Amin Talebi Bezmin Abadi,Shakiba Shafahi Tilaki,Golzar Fattahi et al.
Amin Talebi Bezmin Abadi et al.
Malignant gastrocolic fistula diagnosed by esophagogastroduodenoscopy and colonoscopy [0.03%]
胃镜和结肠镜诊断的恶性胃肠瘘
Molly Orosey,Tusar Desai,Mitual Amin et al.
Molly Orosey et al.
Effect of morning vs. afternoon scheduling of endoscopic US-guided FNA on outcomes of solid pancreatic lesions [0.03%]
内镜超声引导下细针穿刺抽吸胰腺实性病变的效果：上午与下午的差异
Gustavo Gomez,Shailendra Singh,Vamsi Kantamaneni et al.
Gustavo Gomez et al.
Bruno Annibale
Bruno Annibale
Giulia Gibiino,Gianluca Ianiro,Giovanni Cammarota et al.
Giulia Gibiino et al.
The wide assemblage of microorganisms inhabiting our gastrointestinal tract is an attractive field for overwhelming contemporary research in several aspects of the human health. Most recent molecular techniques, as the use of rRNAs or whole...
Effectiveness and safety of infliximab biosimilar CT-P13 in treating ulcerative colitis: a real‑life experience in IBD primary centers [0.03%]
英夫利西单抗类似药CT-P13治疗溃疡性结肠炎的疗效和安全性：IBD中心真实世界经验
Antonio Tursi,Leonardo Allegretta,Stefania Chiri et al.
Antonio Tursi et al.
Background: The aim of this study was to assess the efficacy and safety of infliximab biosimilar (IFX) IFX CT-P13 in inducing and maintaining remission in ulcerative colitis (UC) outpatients in Italian primary gastroenter...
Observational Study
Minerva gastroenterologica e dietologica. 2017 Dec;63(4):313-318. DOI:10.23736/S1121-421X.17.02402-3 2017
Grainne Holleran,Loris R Lopetuso,Gianluca Ianiro et al.
Grainne Holleran et al.
Major advances have occurred in the knowledge of the pathogenesis of inflammatory bowel disease (IBD) over the last decade, and perhaps the most major, and clinically advantageous of these advances has been the discovery of the microbiome a...
Patrizia Zentilin,Elisa Marabotto,Gaia Pellegatta et al.
Patrizia Zentilin et al.
Gastroesophageal reflux disease (GERD) is defined as a condition which develops when the reflux of gastric contents causes troublesome symptoms, impairs quality of life, or leads to mucosal damage or complications. There are two main phenot...